相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein-Coupled Receptors
Celine Valant et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation
Meritxell Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery
Bruce J. Melancon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Molecular Switches on mGluR Allosteric Ligands That Modulate Modes of Pharmacology
Michael R. Wood et al.
BIOCHEMISTRY (2011)
Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): The development of ML169, an MLPCN probe
Paul R. Reid et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Hybrid Molecules Incorporating Natural Products: Applications in Cancer Therapy, Neurodegenerative Disorders and Beyond
M. Decker
CURRENT MEDICINAL CHEMISTRY (2011)
Discovery of a Selective Allosteric M1 Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold
Scott D. Kuduk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
DEMENTIA A problem for our age
Alison Abbott
NATURE (2011)
Neuroprotective therapeutics for Alzheimer's disease: progress and prospects
Alan M. Palmer
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
GPCRs Revisited: New Insights Lead to Novel Drugs
Richard M. Eglen et al.
PHARMACEUTICALS (2011)
Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System
Evan P. Lebois et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Hydroxy cycloalkyl fused pyridone carboxylic acid M1 positive allosteric modulators
Scott D. Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
2' Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling
Brian Budzik et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
2′ Biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR
Brian Budzik et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: Development of a potent and highly selective M1 PAM
Thomas M. Bridges et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M1 positive allosteric modulators
Feng V. Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators
Thomas M. Bridges et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Rational design of dualsteric GPCR ligands: quests and promise
Klaus Mohr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M1 Receptors
Lei Fang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M1 Receptor Agonist with Unprecedented Selectivity and Procognitive Potential
Anette G. Sams et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The M1 Muscarinic Receptor Allosteric Agonists AC-42 and 1-[1′-(2-Methylbenzyl)-1,4′-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one Bind to a Unique Site Distinct from the Acetylcholine Orthosteric Site
Marlene A. Jacobson et al.
MOLECULAR PHARMACOLOGY (2010)
Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
Vimesh A. Avlani et al.
MOLECULAR PHARMACOLOGY (2010)
Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M1 Allosteric Muscarinic Receptor Modulators
Scott D. Kuduk et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists
Brian Budzik et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists
Julia N. Heinrich et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity
Johannes Antony et al.
FASEB JOURNAL (2009)
A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
Jana K. Shirey et al.
JOURNAL OF NEUROSCIENCE (2009)
An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators
Anna Kebig et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2009)
Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
Joy E. Marlo et al.
MOLECULAR PHARMACOLOGY (2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
Lei Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
P. Jeffrey Conn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands
Christopher N Davis et al.
BMC Pharmacology & Toxicology (2009)
Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas - The effect of capping the distal basic piperidine nitrogen
Nicole R. Miller et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1
C. J. Langmead et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Muscarinic Agonists for the Treatment of Cognition in Schizophrenia
Angela K. Sellin et al.
CNS SPECTRUMS (2008)
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
Celine Valant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
Carrie K. Jones et al.
JOURNAL OF NEUROSCIENCE (2008)
G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists
Rachel L. Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease
Abraham Fisher
NEUROTHERAPEUTICS (2008)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Arun K. Shukla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor
Tod Steinfeld et al.
MOLECULAR PHARMACOLOGY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties
Michael Decker
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine:: Evidence for three distinct modes of receptor activation
Tracy A. Spalding et al.
MOLECULAR PHARMACOLOGY (2006)
M1 receptors play a central role in modulating AD-like pathology in transgenic mice
A Caccamo et al.
NEURON (2006)
Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors
T Disingrini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox
Christopher J. Langmead et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease
A Takeda et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Cholinergic function and Alzheimer's disease
E Giacobini
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice
SG Anagnostaras et al.
NATURE NEUROSCIENCE (2003)
Discovery of an ectopic activation site on the M1 muscarinic receptor
TA Spalding et al.
MOLECULAR PHARMACOLOGY (2002)
From models to molecules: Opioid receptor dimers, bivalent ligands, and selective opioid receptor probes
PS Portoghese
JOURNAL OF MEDICINAL CHEMISTRY (2001)
分享论文
